Found 6 matching trials
A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors
PHASE1The primary objective of Phase I of this trial is to evaluate the safety, t...
Location
Anhui Provincial Hospital
Efficacy and Safety Study of Disitamab Vedotin + RC148 vs. Albumin-Paclitaxone Β± Toripalimab in HR-/HER2-low Breast Cancer
PHASE2Evaluating the Efficacy of Disitamab Vedotin in Combination with RC148 Comp...
Location
Cance Hosoltal Chinese Academy of Medical Sciences
A Phase β
‘/β
’ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer
PHASE2This is a Phase β
‘/β
’ study. The purpose of this study is to evaluate the eff...
Location
Beijing Cancer Hospital
A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors
PHASE1This is an open, multi-center, dose escalation and expansion phase I/II stu...
Location
Fujian Cancer Hospital
A Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLC
PHASE1This study will evaluate the efficacy, safety, pharmacokinetics and immunog...
Status
Active Not Recruiting
Location
Beijing Tiantan Hospital of Capital Medical University
RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)
PHASE3This study aims to evaluate the efficacy and safety of RC148 combined with ...
Location
The First Affiliated Hospital of Anhui Medical University